Teresa M Gruber1, Stephan Göttig2, Laura Mark1, Sara Christ1, Volkhard A J Kempf1, Thomas A Wichelhaus1, Axel Hamprecht3. 1. Institute of Medical Microbiology and Infection Control, Hospital of Johann Wolfgang Goethe-University, Frankfurt am Main, Germany. 2. Institute of Medical Microbiology and Infection Control, Hospital of Johann Wolfgang Goethe-University, Frankfurt am Main, Germany stephan.goettig@kgu.de. 3. Institute of Medical Microbiology, Immunology and Hygiene, University Hospital of Cologne, Cologne, Germany.
Abstract
OBJECTIVES: To characterize a pan-drug-resistant Serratia marcescens clinical isolate carrying the New Delhi metallo-β-lactamase (NDM)-1. METHODS: The presence of β-lactamase genes was examined by PCR and sequencing. Antibiotic susceptibility was determined by antibiotic gradient test. Transformation assays, transconjugation assays, PFGE and PCR-based replicon typing were used for plasmid analysis. Horizontal gene transfer was evaluated by liquid mating using Escherichia coli J53 as a recipient. Pathogenicity of NDM-1 expressing S. marcescens was analysed using the Galleria mellonella infection model. RESULTS: S. marcescens isolate SM1890 was non-susceptible to all tested antibiotics, with minocycline retaining intermediate activity. blaNDM-1 was located on a 140 kb IncA/C-type plasmid which was transferable to E. coli and Klebsiella pneumoniae by conjugation. The LD50 of the NDM-positive, SM1890 isolate was higher than that of other, NDM-1 negative, S. marcescens strains. CONCLUSIONS: The presence of a blaNDM-1-harbouring IncA/C plasmid resulted in marked resistance to β-lactam antibiotics, but had no significant effect on virulence of isogenic strains. Because of the intrinsic resistance of S. marcescens to colistin and reduced susceptibility to tigecycline, treatment options for infections by NDM-1-positive isolates are extremely limited in this species.
OBJECTIVES: To characterize a pan-drug-resistant Serratia marcescens clinical isolate carrying the New Delhi metallo-β-lactamase (NDM)-1. METHODS: The presence of β-lactamase genes was examined by PCR and sequencing. Antibiotic susceptibility was determined by antibiotic gradient test. Transformation assays, transconjugation assays, PFGE and PCR-based replicon typing were used for plasmid analysis. Horizontal gene transfer was evaluated by liquid mating using Escherichia coli J53 as a recipient. Pathogenicity of NDM-1 expressing S. marcescens was analysed using the Galleria mellonella infection model. RESULTS:S. marcescens isolate SM1890 was non-susceptible to all tested antibiotics, with minocycline retaining intermediate activity. blaNDM-1 was located on a 140 kb IncA/C-type plasmid which was transferable to E. coli and Klebsiella pneumoniae by conjugation. The LD50 of the NDM-positive, SM1890 isolate was higher than that of other, NDM-1 negative, S. marcescens strains. CONCLUSIONS: The presence of a blaNDM-1-harbouring IncA/C plasmid resulted in marked resistance to β-lactam antibiotics, but had no significant effect on virulence of isogenic strains. Because of the intrinsic resistance of S. marcescens to colistin and reduced susceptibility to tigecycline, treatment options for infections by NDM-1-positive isolates are extremely limited in this species.
Authors: Marko Weidensdorfer; Ju Ik Chae; Celestine Makobe; Julia Stahl; Beate Averhoff; Volker Müller; Christoph Schürmann; Ralf P Brandes; Gottfried Wilharm; Wibke Ballhorn; Sara Christ; Dirk Linke; Doris Fischer; Stephan Göttig; Volkhard A J Kempf Journal: Infect Immun Date: 2015-12-28 Impact factor: 3.441
Authors: John W A Rossen; Jill Dombrecht; Diederik Vanfleteren; Katrien De Bruyne; Alex van Belkum; Sigrid Rosema; Mariette Lokate; Erik Bathoorn; Sandra Reuter; Hajo Grundmann; Julia Ertel; Paul G Higgins; Harald Seifert Journal: J Clin Microbiol Date: 2019-03-28 Impact factor: 5.948
Authors: Alexander M Wailan; Hanna E Sidjabat; Wan Keat Yam; Nabil-Fareed Alikhan; Nicola K Petty; Anna L Sartor; Deborah A Williamson; Brian M Forde; Mark A Schembri; Scott A Beatson; David L Paterson; Timothy R Walsh; Sally R Partridge Journal: Antimicrob Agents Chemother Date: 2016-06-20 Impact factor: 5.191
Authors: Julian Sommer; Kristina M Gerbracht; Felix F Krause; Florian Wild; Manuela Tietgen; Sara Riedel-Christ; Janko Sattler; Axel Hamprecht; Volkhard A J Kempf; Stephan Göttig Journal: Front Microbiol Date: 2021-05-12 Impact factor: 5.640
Authors: Yancheng Yao; Linda Falgenhauer; Volkhard A J Kempf; Michael Hogardt; Stephan Göttig; Can Imirzalioglu; Trinad Chakraborty Journal: Genome Announc Date: 2017-01-19